Patrick T. Sheehan
*** ******** ** *** 2-401-***-****
Charlestown, MA 02129 *******.*.*******@*****.***
Professional Experience
The Broad Institute, June 2010 – August 2013 Chemical Biology Platform
Research Chemist
The Broad Institute, December 2007 – July 2010 Genome Sequencing Platform
Research Associate II
Apogee Technology, Inc., January 2007 – November 2007
Research Scientist
Genzyme, February 2006 – January 2007 Drug Discovery & Design
Analytical R&D Associate
Millennium Pharmaceuticals, Inc., October 2004 – December 2005
Research Assistant, Intern
Education
Suffolk University, Boston, MA
Bachelor of Science in Chemistry
(American Chemical Society Certified) January 2006
GPA 3.06/4.00
Honors: Dean’s List 2003, 2005
Research Experience
The Broad Institute, Research Chemist
● Executed multi-step syntheses to provide leads for fragment based drug discovery against
biological targets
● Performed purification, analysis, and compound characterizati on of synthesized fragment
libraries
● Screened fragment based libraries against biological targets using established methods and
techniques
The Broad Institute, Research Associate II
● Responsible for development, implementation, and method transfer of a size -selective
analytical method for DNA library construction using ion-exchange chromatography
● Investigated and executed new DNA library construction techniques including method
development and method transfer
● Performed routine DNA library construction and analysis using pre -established techniques
and protocols
Apogee Technology, Inc., Research Scientist
● Developed and executed analysis methods for polymer and MEMs based drug delivery
systems
● Created and analyzed formulations for solid state transdermal drug delivery as well design
and develop an accompanying coating device for the delivery system
● Performed routine enzymatic assays and HPLC analysis of in -process formulations and
formulation candidates
Genzyme, Analytical R&D Associate
● Accountable for analytical chemistry method execution and project assistance for new drug
trials
● Completed work within appropriate regulatory requirements, including FDA, EPA, Good
Laboratory Practices (GLP), and FDA current Good Manufacturing Practices (cGMPs)
● Provide investigations, and problem solving solutions for new drug candidates
Millennium Pharmaceuticals, Inc., Research Assistant, Intern
● Independently performed multistep organic synthesis using modern synthetic, purification,
and characterization techniques for an oncology drug
Investigated, designed and executed organic synthetic methods for 2H stable-isotope
●
compounds for a commercial product
● Characterized compounds by spectrometric techniques such as LC-MS, HPLC, and FT-
NMR to monitor the progress of the compound throughout the synthesis
Publications
“Selective Access to Trisubstituted Macrocyclic E- and Z-Alkenes from the Ring-Closing Metathesis
of Vinylsiloxanes” Y. Wang, M. Jimenez, P. Sheehan, C. Zhong, A. W. Hung, D.W. Young. Org.
Lett., 2013, 15 (6), pp 1218-122.
"Diversity-Oriented Synthesis Approach to Fragment-Based Screening" Wang, Y., Wach, JY,
Sheehan, P., Zhong, C., Zhan, C,. Harris, R., Almo, S, Bishop, J, Haggarty, S., Ramek, A., Berry, K.,
O'Herin, C., Koehler, A., Hung, A., Young, D.W., ACS Chem. Bio., Submitted July 2013.
“A Strategy Toward Enantioenriched Functionalized sp 2-sp3 Hybrid Heterocycles.” Wacht,, Jean-
Yves; Sheehan, Patrick; Schreiber, Stuart L.; Young, Damian. Org. Lett., Submitted August 2013.
“Synthesis of Four Isotopically Labeled Forms of a Proteasome Inhibitor, Bortezomib” Y. Li, M.
Plesescu, P. Sheehan, J. S. Daniels, S. Prakash. J. Labelled Comp. Radiopharm., 2007, 50 (5-6), pp
402-406.